Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 26:24:71-73.
doi: 10.1016/j.jdcr.2022.04.015. eCollection 2022 Jun.

Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans

Cara Barber  1 , Eingun James Song  2
Affiliations
Case Reports

Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans

Cara Barber et al. JAAD Case Rep. .
No abstract available

Keywords: TMEP, elangiectasia macularis eruptiva perstans; biologics; cutaneous mastocytosis; malignancy; plaque psoriasis; risankizumab; systemic mastocytosis; telangictasia macularis eruptiva perstans.

PubMed Disclaimer

Conflict of interest statement

Cara Barber has no conflicts of interest to report. Dr. Eingun James Song, MD, has been a consultant, speaker or investigator for the following companies: AbbVie, Janssen, Amgen, Lilly, SUN, UCB, Incyte, Novartis, Sanofi & Regeneron, Castle Biosciences, and Pfizer.

Figures

Fig 1
Fig 1
Photos of the patient from the time of original diagnosis of telangiectasia macularis eruptiva perstans. The characteristic ruddy brown telangiectatic macules were appreciated on (A) his back and (B) abdomen.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Costa D.L., Moura H.H., Rodrigues R., Pineiro-Maceira J., Ramos-E-Silva M. Telangiectasia macularis eruptiva perstans: a rare form of adult mastocytosis. J Clin Aesthet Dermatol. 2011;4(10):52–54. - PMC - PubMed
    1. Bates W.D., Gray D.W., Dada M.A., et al. Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol. 2003;56(6):439–446. doi: 10.1136/jcp.56.6.439. - DOI - PMC - PubMed
    1. Nocturne G., Boudaoud S., Ly B., Pascaud J., Paoletti A., Mariette X. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. J Autoimmun. 2017;80:56–64. doi: 10.1016/j.jaut.2017.02.001. - DOI - PubMed
    1. Yang K., Oak A.S.W., Elewski B.E. Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review. Am J Clin Dermatol. 2021;22(2):173–192. doi: 10.1007/s40257-020-00578-0. - DOI - PMC - PubMed
    1. Severino M., Chandesris M.O., Barete S., et al. Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement. J Am Acad Dermatol. 2016;74(5):885–891.e1. doi: 10.1016/j.jaad.2015.10.050. - DOI - PubMed

Publication types

LinkOut - more resources